135 related articles for article (PubMed ID: 15335180)
1. Effects of the long-acting calcium channel blockers, amlodipine, manidipine and cilnidipine on steroid hormones and insulin resistance in hypertensive obese patients.
Ueshiba H; Miyachi Y
Intern Med; 2004 Jul; 43(7):561-5. PubMed ID: 15335180
[TBL] [Abstract][Full Text] [Related]
2. Effects of amlodipine on serum levels of adrenal androgens and insulin in hypertensive men with obesity.
Ueshiba H; Tsuboi K; Miyachi Y
Horm Metab Res; 2001 Mar; 33(3):167-9. PubMed ID: 11355751
[TBL] [Abstract][Full Text] [Related]
3. The calcium channel blocker amlodipine raises serum dehydroepiandrosterone sulfate and androstenedione, but lowers serum cortisol, in insulin-resistant obese and hypertensive men.
Beer NA; Jakubowicz DJ; Beer RM; Nestler JE
J Clin Endocrinol Metab; 1993 Jun; 76(6):1464-9. PubMed ID: 8501151
[TBL] [Abstract][Full Text] [Related]
4. Disparate effects of insulin reduction with diltiazem on serum dehydroepiandrosterone sulfate levels in obese hypertensive men and women.
Beer NA; Jakubowicz DJ; Beer RM; Nestler JE
J Clin Endocrinol Metab; 1994 Oct; 79(4):1077-81. PubMed ID: 7962276
[TBL] [Abstract][Full Text] [Related]
5. Antiproteinuric effect of cilnidipine in hypertensive Japanese treated with renin-angiotensin-system inhibitors - a multicenter, open, randomized trial using 24-hour urine collection.
Miwa Y; Tsuchihashi T; Ohta Y; Tominaga M; Kawano Y; Sasaguri T; Ueno M; Matsuoka H
Clin Exp Hypertens; 2010; 32(6):400-5. PubMed ID: 20828221
[TBL] [Abstract][Full Text] [Related]
6. Comparison between cilnidipine and amlodipine besilate with respect to proteinuria in hypertensive patients with renal diseases.
Kojima S; Shida M; Yokoyama H
Hypertens Res; 2004 Jun; 27(6):379-85. PubMed ID: 15253102
[TBL] [Abstract][Full Text] [Related]
7. Effects of amlodipine-atorvastatin combination on inflammation markers and insulin sensitivity in normocholesterolemic obese hypertensive patients.
Fogari R; Preti P; Zoppi A; Lazzari P; Corradi L; Fogari E; Ciccarelli L; Derosa G
Eur J Clin Pharmacol; 2006 Oct; 62(10):817-22. PubMed ID: 16896785
[TBL] [Abstract][Full Text] [Related]
8. On the top of ARB N/L type Ca channel blocker leads to less elevation of aldosterone.
Konoshita T; Kaeriyama S; Urabe M; Nakaya T; Yamada M; Ichikawa M; Yamamoto K; Sato S; Imagawa M; Fujii M; Makino Y; Zenimaru Y; Wakahara S; Suzuki J; Ishizuka T; Nakamura H;
Biosci Rep; 2016 Oct; 36(5):. PubMed ID: 27515419
[TBL] [Abstract][Full Text] [Related]
9. Impact of azelnidipine and amlodipine on left ventricular mass and longitudinal function in hypertensive patients with left ventricular hypertrophy.
Motoki H; Koyama J; Izawa A; Tomita T; Miyashita Y; Takahashi M; Ikeda U
Echocardiography; 2014 Nov; 31(10):1230-8. PubMed ID: 24645985
[TBL] [Abstract][Full Text] [Related]
10. Dehydroepiandrosterone sulfate levels in women. Relationships with body mass index, insulin and glucose levels.
Al-Harithy RN
Saudi Med J; 2003 Aug; 24(8):837-41. PubMed ID: 12939667
[TBL] [Abstract][Full Text] [Related]
11. Effects of manidipine and delapril in hypertensive patients with type 2 diabetes mellitus: the delapril and manidipine for nephroprotection in diabetes (DEMAND) randomized clinical trial.
Ruggenenti P; Lauria G; Iliev IP; Fassi A; Ilieva AP; Rota S; Chiurchiu C; Barlovic DP; Sghirlanzoni A; Lombardi R; Penza P; Cavaletti G; Piatti ML; Frigeni B; Filipponi M; Rubis N; Noris G; Motterlini N; Ene-Iordache B; Gaspari F; Perna A; Zaletel J; Bossi A; Dodesini AR; Trevisan R; Remuzzi G;
Hypertension; 2011 Nov; 58(5):776-83. PubMed ID: 21931073
[TBL] [Abstract][Full Text] [Related]
12. Manidipine in hypertensive patients with metabolic syndrome: the MARIMBA study.
Martínez Martín FJ
Expert Rev Cardiovasc Ther; 2009 Jul; 7(7):863-9. PubMed ID: 19589122
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the anti-hypertensive effects of the L/N-type calcium channel antagonist cilnidipine, and the L-type calcium channel antagonist amlodipine in hypertensive patients with cerebrovascular disease.
Takei K; Araki N; Ohkubo T; Tamura N; Yamamoto T; Furuya D; Yanagisawa CT; Shimazu K
Intern Med; 2009; 48(16):1357-61. PubMed ID: 19687579
[TBL] [Abstract][Full Text] [Related]
14. Effects of 3-month nifedipine treatment on endocrine-metabolic parameters in patients with abdominal obesity and mild hypertension.
Maccario M; Oleandri SE; Avogadri E; Rossetto R; Grottoli S; Procopio M; Camanni F; Ghigo E
J Endocrinol Invest; 1998 Jan; 21(1):56-63. PubMed ID: 9633024
[TBL] [Abstract][Full Text] [Related]
15. Effects of cilnidipine on sympathetic nerve activity and cardiorenal function in hypertensive patients with type 2 diabetes mellitus: association with BNP and aldosterone levels.
Tanaka M; Sekioka R; Nishimura T; Ichihara A; Itoh H
Diabetes Res Clin Pract; 2014 Dec; 106(3):504-10. PubMed ID: 25458339
[TBL] [Abstract][Full Text] [Related]
16. Effect of delapril/manidipine vs olmesartan/ hydrochlorothiazide combination on insulin sensitivity and fibrinogen in obese hypertensive patients.
Fogari R; Derosa G; Zoppi A; Lazzari P; Corradi L; Preti P; Mugellini A
Intern Med; 2008; 47(5):361-6. PubMed ID: 18310964
[TBL] [Abstract][Full Text] [Related]
17. Antiproteinuric effect of the calcium channel blocker cilnidipine added to renin-angiotensin inhibition in hypertensive patients with chronic renal disease.
Fujita T; Ando K; Nishimura H; Ideura T; Yasuda G; Isshiki M; Takahashi K;
Kidney Int; 2007 Dec; 72(12):1543-9. PubMed ID: 17943080
[TBL] [Abstract][Full Text] [Related]
18. Effect of cilnidipine on insulin sensitivity in patients with essential hypertension.
Yagi S; Goto S; Yamamoto T; Kurihara S; Katayama S
Hypertens Res; 2003 May; 26(5):383-7. PubMed ID: 12887129
[TBL] [Abstract][Full Text] [Related]
19. The N- and L-type calcium channel blocker cilnidipine suppresses renal injury in dahl rats fed a high-sucrose diet, an experimental model of metabolic syndrome.
Konda T; Enomoto A; Matsushita J; Takahara A; Moriyama T
Nephron Physiol; 2005; 101(1):p1-13. PubMed ID: 15886499
[TBL] [Abstract][Full Text] [Related]
20. L/N-type calcium channel blocker cilnidipine ameliorates proteinuria and inhibits the renal renin-angiotensin-aldosterone system in deoxycorticosterone acetate-salt hypertensive rats.
Toba H; Yoshida M; Tojo C; Nakano A; Oshima Y; Kojima Y; Noda K; Wang J; Kobara M; Nakata T
Hypertens Res; 2011 Apr; 34(4):521-9. PubMed ID: 21270815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
